In this podcast, Steven Grinspoon, MD, discusses his latest research on the effects of tesamorelin use on non-alcoholic fatty liver disease (NAFLD) in patients with HIV, how the increase in obesity among patients with HIV affects the risk for NAFLD, and more. More at: www.consultant360.com/infectious-diseases.